ATP Citrate Lyase is a General Tumour Biomarker and Contributes to the Development of Cutaneous Squamous Cell Carcinoma

In conclusion, ATP citrate lyase may serve as a tumour biomarker. It is highly expressed in cutaneous squamous cell carcinoma and may serve as a therapeutic target.PMID:38590175 | DOI:10.2340/actadv.v104.23805
Source: Acta Dermato-Venereologica - Category: Dermatology Authors: Source Type: research